The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
Clinical trial NCT04654390 · COMPLETED
Trial details
- NCT number
- NCT04654390
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2021-12-17
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.